Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestorsHeatmap
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
CTKB
Cytek Biosciences, Inc. CTKB
$4.04
โ–ผ -1.49% 24H
2.428.4214.4220.4326.432021-072022-102024-012025-032026-06

About

Cytek Biosciences Inc. is a biotechnology company that specializes in advancing the capabilities of flow cytometry technologies. Its primary function is to develop and deliver transformative, cost-effective products for researchers and clinicians in the life sciences sector. The company is renowned for its full spectruโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees678
TickerCTKB

Statistics

Market Cap$521.1M
Revenue (TTM)$201.5M
Net Income-$66.5M
Net Margin-33.0%
EPSโ€”
P/E374.50
P/S2.54
P/B1.58
EV/EBITDA-7.94
ROE-20.9%
Dividend Yieldโ€”
Price$4.04

Data: Twelve Data ยท Revenue = mcap / P/S

Cytek Biosciences, Inc. (CTKB) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap